First Time Loading...
Search stocks here...
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing About Contact Us
Sign Up Log in

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 6 GBX -5.88% Market Closed
Updated: May 31, 2023
FAB
/
Profitability
/
Operating Margin

Operating Margin

According to Fusion Antibodies PLC's latest financial reports the company's operating margin is -46%.

-45.8%
Current
-31.6%
Average
7.4%
Industry
What is Operating Margin?

Operating Margin History

Statistics
Operating Margin

1 Year 3 Years 5 Years
Average -33.9% -31.6% -39.2%
Median -28.4% -28.4% -29.2%
Min -45.8% -45.8% -75.2%
Max -27.6% -24.9% -24.9%

History Chart
Operating Margin

Operating Margin Distribution

Operating Margin Distribution
Life Sciences Tools & Services Industry

Operating Margin Across Competitors

Operating Margin Comparison
Fusion Antibodies PLC Competitors

Country Company Market Cap Operating
Margin
UK
Fusion Antibodies PLC
LSE:FAB
1.6M GBP
-46%
US
Thermo Fisher Scientific Inc
NYSE:TMO
198B USD
17%
US
Danaher Corp
NYSE:DHR
166B USD
27%
CH
Lonza Group AG
SIX:LONN
42.3B CHF
25%
KR
Samsung Biologics Co Ltd
KRX:207940
55.5T KRW
31%
US
IQVIA Holdings Inc
NYSE:IQV
36.8B USD
13%
US
Agilent Technologies Inc
NYSE:A
34.7B USD
24%
US
Illumina Inc
NASDAQ:ILMN
30.7B USD
2%
US
Mettler-Toledo International Inc
NYSE:MTD
29B USD
29%
CN
WuXi AppTec Co Ltd
SSE:603259
192B CNY
24%
US
West Pharmaceutical Services Inc
NYSE:WST
25B USD
25%
Fusion Antibodies PLC
LSE:FAB
Country UK
Market Cap 1.6M GBP
Operating Margin
-46%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 198B USD
Operating Margin
17%
Danaher Corp
NYSE:DHR
Country US
Market Cap 166B USD
Operating Margin
27%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 42.3B CHF
Operating Margin
25%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.5T KRW
Operating Margin
31%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 36.8B USD
Operating Margin
13%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 34.7B USD
Operating Margin
24%
Illumina Inc
NASDAQ:ILMN
Country US
Market Cap 30.7B USD
Operating Margin
2%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 29B USD
Operating Margin
29%
WuXi AppTec Co Ltd
SSE:603259
Country CN
Market Cap 192B CNY
Operating Margin
24%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 25B USD
Operating Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.

Full Profitability Report

See Also

Summary
FAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
FAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FAB stock valuation using valuation multiples.
Wall Street Estimates
FAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Similar Stocks
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
=
Operating Profit
/
Revenue
ALPHA SPREAD
Join more than 54,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy Affiliate Program

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2023 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.